Heart failure breakthrough may come from “open source” cancer drug development
The Plain Dealer: When Saptarsi Haldar, assistant professor of medicine, had a hunch the same mechanism at work in cancer cells also might be implicated in heart failure, he asked researchers at the Dana-Farber Cancer Institute for a sample of the drug that potentially could treat both.
